Chemical Structure : Varilutamide
Catalog No.: PC-27513Not For Human Use, Lab Use Only.
Varilutamide (ONC1-13B) is a potent, nonsteroidal antagonist of androgen receptor, inhibits DHT-induced PSA expression with Ki of 20 nM, fully inhibits androgen-dependent gene expression.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Varilutamide (ONC1-13B) is a potent, nonsteroidal antagonist of androgen receptor (AR), inhibits DHT-induced PSA expression with Ki of 20 nM, fully inhibits androgen-dependent gene expression.
Varilutamide (ONC1-13B) is around 10-fold more efficiently than bicalutamide (Ki 190 nM).
Varilutamide (ONC1-13B) inhibits DHT-induced cell proliferation of LnCAP cells.
Varilutamide (ONC1-13B) can completely inhibit 6a-Fluotestosterone induced AR nuclear translocation.
Varilutamide (ONC1-13B) ONC1-0013B (20 and 50 mg/kg once daily) efficiently inhibits tumor growth in the xenograft model of prostate cancer.
| M.Wt | 492.45 | |
| Formula | C22H16F4N4O3S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Ivachtchenko AV, et al. J Cancer. 2014 Jan 21;5(2):133-42.
2. Ivachtchenko AV, et al. Eur J Med Chem. 2015 Jun 24;99:51-66.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright